Inovalon (INOV) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Inovalon Reports Fourth Quarter and Full Year 2014 Results
March 25, 2015 4:05 PM EDTBOWIE, Md., March 25, 2015 /PRNewswire/ --
Record full year revenue of $361.5 million, a 22% year-over-year increase Adjusted EBITDA for the year of $133.6 million, a 86% year-over-year increase, reflecting a 37% Adjusted EBITDA margin Non-GAAP full year net income of $70.2 million, resulting in Non-GAAP diluted net income per share of $0.53, an increase of 96% year-over-year Record 575 Contracted Patient Population Statements of Work in 2014, a 62% year-over-year increaseInovalon (Nasdaq: INOV), a leading technology company providing advanced cloud-based data analytics and data-driven intervention platforms to the health care... More
